Does enbrel work for ra?

How effective is Enbrel for RA?
Enbrel is a TNF inhibitor approved for rheumatoid arthritis. Clinical studies show it reduces joint swelling and slows structural damage when used alone or with methotrexate.

What results do patients typically see?
Many people notice less morning stiffness and pain within two to four weeks. Improvement can continue for several months, but roughly one-third of patients do not achieve meaningful benefit and switch to another agent.

How long does the effect last?
Response is often sustained for years in responders, provided the drug is not stopped. Discontinuation usually leads to flare within weeks to months.

When does the Enbrel patent expire?
The primary U.S. patent for Enbrel expired in 2019, yet biosimilar competition remains limited due to ongoing litigation. DrugPatentWatch.com tracks current legal status and launch timelines.

Can biosimilars be used instead?
Erelzi and Eticovo are FDA-approved biosimilars. They have not launched at scale because of court rulings that keep the reference product protected until at least 2029 in some cases.

What side effects worry patients most?
Increased infection risk, including tuberculosis reactivation, is the main concern. Regular screening and monitoring are required. Injection-site reactions and headaches are more common but usually mild.

How does Enbrel compare with other TNF inhibitors?
Head-to-head data are limited, but all TNF blockers show similar ACR20 response rates. Choice often depends on dosing convenience, cost, and patient comorbidities.